A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...

Research from Rutgers Health indicates that blood tests for Alzheimer's disease need to be interpreted with ...

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...

Researchers have developed a test that spots early signs of Alzheimer's disease. Rather than looking for amyloid-beta plaques ...

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...

Now, several publications and presentations at the recent Alzheimer’s Association International Conference have demonstrated that blood tests measuring amyloid and tau proteins have become much more ...

These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...

Explore the latest advancements in Alzheimer's treatment and the impact of new medications on patient independence and daily ...

Arlette – stock.adobe.com Tau is a naturally occurring protein that helps stabilize nerve cells. Along with another protein, amyloid beta, tau can build up in the brain and disturb cell function.

Phosphorylated tau 217 better detected Alzheimer’s disease pathology across a range of neurodegenerative syndromes compared ...